Daiwa Securities Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
277
| – | – | ﹤0.01% | 1256 |
|
|
2025
Q1 | $0 | Hold |
277
| – | – | ﹤0.01% | 1289 |
|
|
2024
Q4 | $0 | Hold |
277
| – | – | ﹤0.01% | 1295 |
|
|
2024
Q3 | $1K | Hold |
277
| – | – | ﹤0.01% | 1247 |
|
|
2024
Q2 | $1K | Sell |
277
-6,913
| -96% | -$25K | ﹤0.01% | 1276 |
|
|
2024
Q1 | $53K | Sell |
7,190
-452
| -6% | -$3.33K | ﹤0.01% | 1100 |
|
|
2023
Q4 | $77K | Sell |
7,642
-680
| -8% | -$6.85K | ﹤0.01% | 1043 |
|
|
2023
Q3 | $65K | Hold |
8,322
| – | – | ﹤0.01% | 1043 |
|
|
2023
Q2 | $68K | Buy |
8,322
+8,045
| +2,904% | +$65.7K | ﹤0.01% | 1051 |
|
|
2023
Q1 | $2K | Hold |
277
| – | – | ﹤0.01% | 1202 |
|
|
2022
Q4 | $2K | Buy |
277
+77
| +39% | +$556 | ﹤0.01% | 1212 |
|
|
2022
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 1217 |
|
|
2022
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 1220 |
|
|
2022
Q1 | $4K | Hold |
200
| – | – | ﹤0.01% | 1184 |
|
|
2021
Q4 | $5K | Sell |
200
-34
| -15% | -$850 | ﹤0.01% | 1186 |
|
|
2021
Q3 | $10K | Buy |
234
+101
| +76% | +$4.32K | ﹤0.01% | 1136 |
|
|
2021
Q2 | $8K | Hold |
133
| – | – | ﹤0.01% | 1047 |
|
|
2021
Q1 | $6K | Buy |
133
+16
| +14% | +$722 | ﹤0.01% | 1067 |
|
|
2020
Q4 | $8K | Sell |
117
-187
| -62% | -$12.8K | ﹤0.01% | 1025 |
|
|
2020
Q3 | $9K | Hold |
304
| – | – | ﹤0.01% | 1035 |
|
|
2020
Q2 | $6K | Hold |
304
| – | – | ﹤0.01% | 1081 |
|
|
2020
Q1 | $6K | Hold |
304
| – | – | ﹤0.01% | 1079 |
|
|
2019
Q4 | $9K | Hold |
304
| – | – | ﹤0.01% | 1063 |
|
|
2019
Q3 | $7K | Hold |
304
| – | – | ﹤0.01% | 1039 |
|
|
2019
Q2 | $8K | Hold |
304
| – | – | ﹤0.01% | 1047 |
|
|
2019
Q1 | $7K | Buy |
304
+71
| +30% | +$1.64K | ﹤0.01% | 1040 |
|
|
2018
Q4 | $5K | Hold |
233
| – | – | ﹤0.01% | 1041 |
|
|
2018
Q3 | $7K | Hold |
233
| – | – | ﹤0.01% | 1048 |
|
|
2018
Q2 | $8K | Hold |
233
| – | – | ﹤0.01% | 1054 |
|
|
2018
Q1 | $8K | Buy |
+233
| New | +$8K | ﹤0.01% | 1036 |
|